XML 59 R48.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended 48 Months Ended
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2015
Dec. 31, 2019
Oct. 27, 2014
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Balance, beginning of period $ 194,054 $ 192,190 $ 192,762 $ 195,655 $ 195,981 $ 194,532 $ 192,762 $ 194,532      
Common stock options exercised 624 72 441 35 232            
Purchase of subsidiary shares from noncontrolling interest         (413)            
Sale of subsidiary shares to noncontrolling interests 396                    
Reclassification out of accumulated other comprehensive income and non-controlling interest upon the deconsolidation of a subsidiary           (617)   (617)      
Stock-based compensation 648 641 643 583 568 558          
Net income (loss) 1,481 959 217 (495) 1,738 (1,023) 2,657 220      
Net dividend declared by joint ventures   (89)                  
Other comprehensive income (loss) 4,689 281 (1,873) (4,324) (2,451) 2,531          
Balance, end of period 201,892 194,054 192,190 191,454 195,655 195,981 201,892 191,454   $ 192,762  
Reclassification adjustment from AOCI 0     0     0 0      
Stock repurchase program, authorized amount                     $ 5,000
Shares repurchased (in shares)                 908,000 0  
Average price of shares repurchased (in dollars per share)                 $ 2.52    
Total purchase price                 $ 2,300    
Stock repurchase program remaining authorized repurchase amount 2,700           2,700        
Preferred Stock                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Balance, beginning of period 3,532 3,532 3,532 3,532 3,532 3,532 3,532 3,532      
Balance, end of period 3,532 3,532 3,532 3,532 3,532 3,532 3,532 3,532   $ 3,532  
Common Stock                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Balance, beginning of period 41 41 41 40 40 40 41 40      
Balance, end of period 41 41 41 40 40 40 41 40   41  
Additional Paid-In Capital                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Balance, beginning of period 238,754 238,041 236,957 235,702 234,976 234,418 236,957 234,418      
Common stock options exercised 624 72 441 35 232            
Purchase of subsidiary shares from noncontrolling interest         (74)            
Sale of subsidiary shares to noncontrolling interests 396                    
Stock-based compensation 648 641 643 583 568 558          
Balance, end of period 240,422 238,754 238,041 236,320 235,702 234,976 240,422 236,320   236,957  
Accumulated Deficit                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Balance, beginning of period (47,600) (47,961) (47,783) (44,836) (46,287) (45,183) (47,783) (45,183)      
Net income (loss) 991 361 (178) (898) 1,451 (1,104)          
Balance, end of period (46,609) (47,600) (47,961) (45,734) (44,836) (46,287) (46,609) (45,734)   (47,783)  
Accumulated Other Comprehensive Income (Loss)                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Balance, beginning of period (6,365) (6,637) (4,862) (3,130) (733) (1,972) (4,862) (1,972)      
Reclassification out of accumulated other comprehensive income and non-controlling interest upon the deconsolidation of a subsidiary           (1,150)          
Other comprehensive income (loss) 4,373 272 (1,775) (4,110) (2,397) 2,389          
Balance, end of period (1,992) (6,365) (6,637) (7,240) (3,130) (733) (1,992) (7,240)   (4,862)  
AXT, Inc. Stockholders' Equity                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Balance, beginning of period 188,362 187,016 187,885 191,308 191,528 190,835 187,885 190,835      
Common stock options exercised 624 72 441 35 232            
Purchase of subsidiary shares from noncontrolling interest         (74)            
Sale of subsidiary shares to noncontrolling interests 396                    
Reclassification out of accumulated other comprehensive income and non-controlling interest upon the deconsolidation of a subsidiary           (1,150)          
Stock-based compensation 648 641 643 583 568 558          
Net income (loss) 991 361 (178) (898) 1,451 (1,104)          
Other comprehensive income (loss) 4,373 272 (1,775) (4,110) (2,397) 2,389          
Balance, end of period 195,394 188,362 187,016 186,918 191,308 191,528 195,394 186,918   187,885  
Noncontrolling Interests                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Balance, beginning of period 5,692 5,174 4,877 4,347 4,453 3,697 4,877 3,697      
Purchase of subsidiary shares from noncontrolling interest         (339)            
Reclassification out of accumulated other comprehensive income and non-controlling interest upon the deconsolidation of a subsidiary           533          
Net income (loss) 490 598 395 403 287 81          
Net dividend declared by joint ventures   (89)                  
Other comprehensive income (loss) 316 9 (98) (214) (54) 142          
Balance, end of period $ 6,498 $ 5,692 $ 5,174 $ 4,536 $ 4,347 $ 4,453 $ 6,498 $ 4,536   $ 4,877